The effect of catechol-O-methyl transferase inhibitors on behavior and dopamine metabolism.
D000438:Alcohols / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000378:metabolism / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000378:metabolism*; D002250:Carbon Radioisotopes; D065098:Catechol O-Methyltransferase Inhibitors; D002415:Cats; D002421:Caudate Nucleus / Q000187:drug effects / Q000378:metabolism; D002746:Chlorpromazine / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D003508:Cycloheptanes / Q000494:pharmacology*; D004298:Dopamine / Q000096:biosynthesis / Q000378:metabolism*; D007700:Kinetics; D011748:Pyrogallol / Q000494:pharmacology*; D011804:Quinolines / Q000494:pharmacology*; D051381:Rats; D012436:S-Adenosylmethionine; D013997:Time Factors; D014316:Tritium; D014443:Tyrosine / Q000378:metabolism
D000438:Alcohols; D002250:Carbon Radioisotopes; D065098:Catechol O-Methyltransferase Inhibitors; D003508:Cycloheptanes; D011804:Quinolines; D011748:Pyrogallol; D014316:Tritium; D014443:Tyrosine; D012436:S-Adenosylmethionine; D001058:Apomorphine; D002746:Chlorpromazine; D004298:Dopamine